Volver

Medtronic PLC

Ticker: MDT ISIN: IE00BTN1Y115
Añadir al portafolio Análisis de cartera en 2min
Stock Large-cap Dividend payer
Capitalización
100,09 MM $
P/E
21,78
Forward P/E
12,76
Profit margin
13,00%
Revenue growth QoQ
8,70%
Div. yield
3,65%
Beta
0,63
92,90 $ -0,48%
Precio a fecha de 2026-08-24 · NYSE

Rendimiento por período

Rendimientos acumulados
1 Month +10,31%
6 Months -2,32%
1 Year +4,22%
5 Years -4,02% p.a.-18,53%
10 Years +3,32% p.a.+38,61%
Since inception +4,95% p.a.+234,33%
Rendimientos por año
YTD -1,62%
2025 +24,05%
2024 +0,28%
2023 +9,58%
2022 -22,55%
2021 -9,79%

Key stats

Market cap
100,09 MM
P/E
21,78
Dividend yield
3,65%
Beta
0,63
52-week range
75.91 - 104.70
50-day MA
86,76
200-day MA
93,91
Section 1

Business overview

Company profile data from fundamentals.

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Sector Healthcare
Industry Medical Devices
Country Ireland
Exchange NYSE
Section 2

Financial quality

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE 9,39%
ROA 4,57%
Profit margin 13,00%
Operating margin 20,01%
PEG ratio 1,36
Revenue/share TTM 27,68
Revenue TTM 35,48 MM
EBITDA 9,44 MM
Gross profit TTM 23,12 MM
Beta 0,63

Valuation

Trailing P/E 21,78
Forward P/E 12,76
P/B 2,04
P/S 2,82
EV/EBITDA 12,78
EV/Revenue 3,37

ESG Scores

Total ESG 26,9
Environment 4,1
Social 15,3
Governance 9,0
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 5,53
Quarterly earnings growth -11,80%
Revenue TTM 35,48 MM
Reported quarters 121
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Dividend yield 3,65%
Forward annual div. yield 2,83%
Dividend per share 2,8300
Payout ratio 50,27%
Ex-dividend date 2025-12-26
Split factor 2:1
Last split date 1999-09-27
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Analyst

Analyst target price 110,97 $
Analyst rating 3.8125

Ownership & short interest

Shares outstanding 1,28 MM
Shares float 1,28 MM
Institutional ownership 88,43%
Insider ownership 29,40%
Short ratio 1,96
Short % of float 1,21%

Details

Instrument metadata and source update timestamps.

Symbol MDT
Name Medtronic PLC
Asset type STOCK
Exchange NYSE
Currency USD
ISIN IE00BTN1Y115
Country USA
Code + exchange MDT.NYSE
Last price date 2026-05-08
Fundamentals updated 2026-05-08

La información proporcionada en esta plataforma es solo para fines informativos y no debe considerarse como asesoramiento financiero o de inversión. Insightfolio no ofrece asesoramiento financiero, recomendaciones personalizadas ni orientación sobre la compra, tenencia o venta de activos financieros. Las herramientas y contenidos son únicamente educativos y no están adaptados a las circunstancias, necesidades financieras u objetivos personales.

Insightfolio no asume ninguna responsabilidad por la precisión, integridad o fiabilidad de la información presentada. Es responsabilidad exclusiva de los usuarios verificar la información y tomar decisiones independientes basándose en su propia investigación y consideración. El uso de esta plataforma no reemplaza la consulta con profesionales financieros cualificados.

Invertir implica riesgos. Los usuarios deben ser conscientes de que el valor de las inversiones puede fluctuar y que los rendimientos pasados no son garantía de resultados futuros. Las decisiones de inversión deben basarse en objetivos financieros personales, tolerancia al riesgo y una evaluación independiente de la información relevante.

Insightfolio no respalda ni garantiza la idoneidad de ningún producto financiero, valor o estrategia en particular. Cualquier proyección, pronóstico o escenario hipotético presentado en la plataforma es solo ilustrativo y no constituye una garantía.

Al acceder a los servicios, información o contenido ofrecido por Insightfolio, los usuarios reconocen y aceptan los términos de este aviso legal. Si no estás de acuerdo con estos términos, por favor no uses nuestra plataforma.

Logotipos de instrumentos proporcionados por Elbstream.